The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a ...

Glioblastoma (GBM), one of the ... and 12,000 new cases are diagnosed every year. The disease, which accounts for nearly half (49%) of all brain tumors, has an extremely low survival rate, with ...

Glioblastoma (GBM), one of the ... and 12,000 new cases are diagnosed every year. The disease, which accounts for nearly half (49%) of all brain tumors, has an extremely low survival rate, with ...

Glioblastoma, one of the most aggressive and lethal brain cancers, has a five-year survival rate of only 6.9%, according to the National Brain Tumor Society. While the relationship between ...

The Brain Prize 2025 went to neuro-oncologists Michelle Monje and Frank Winkler for pioneering the field of cancer n.

New research shows that the adult brain can generate new neurons that integrate into key motor circuits, findings that may point to a new way to treat neurogenerative disorders.

Mouse studies demonstrated that newly generated neurons connect with brain networks responsible for motor control.

Treatment with VXM01, an investigational vaccine, plus Bavencio demonstrated both safety and tolerability in patients with recurrent glioblastoma.

Feb. 26, 2025 — Scientists have identified a potential new strategy for treating glioblastoma ... Brain Tumors Oct. 17, 2024 — Research provides evidence that a drug used to slow the ...